Detailed price information for Raysearch Labs Ab Ord (RSLBF) from The Globe and Mail including charting and trades.

STOCKHOLM, July 25, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce its participation at AAPM in Washington, D.C., July 27-30, where state of the art innovations under the ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) has been awarded a contract for a new adaptive radiation therapy solution at Princess Margaret Hospital (PMH) in ...

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce our participation at ESTRO in Vienna, Austria, May 3-5, where we will present groundbreaking innovations ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) announces that version 3.5 of RaySearch's RayStation® treatment planning system has been released for clinical use in ...

STOCKHOLM, July 4, 2018 /PRNewswire/ -- Kobe Proton Center in Japan has recently started clinical application of RayStation 7 for treatment. The first patient was treated in March 2018 using the ...

RaySearch Laboratories and its clinical customers are leveraging advances in machine learning to reimagine the radiotherapy workflow Data-driven oncology: a growing number of clinical customers are ...

STOCKHOLM, July 1, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024B, the latest version of the company's innovative treatment planning system. The new ...

Detailed price information for Raysearch Labs Ab Ord (RSLBF) from The Globe and Mail including charting and trades.

RaySearch Laboratories AB (publ) is pleased to announce that Institut de Radiothérapie et de Radiochirurgie Hartmann has selected RayStation ®* and RayCare®* to improve clinical workflows across a ...

RaySearch is proud to announce that the first patient has been successfully treated using RayStation at the Poltava Regional Cancer Clinic in Ukraine. This milestone, achieved in partnership with the ...